Handa, Japan

Takashi Mano

This inventor holds 12 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1991-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Mano. Retrieved from https://idiyas.com/inventor/takashi-mano-ktrklkrk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 91.7

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 54(Granted Patents)


Location History:

  • Aichi, JP (1995 - 1998)
  • Seishiro-Cho, JP (1999 - 2000)
  • Handa, JP (1991 - 2001)
  • Aichi-ken, JP (2001 - 2004)

Company Filing History:


Years Active: 1991-2004

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Takashi Mano: Innovator in Pharmaceutical Chemistry

Introduction

Takashi Mano is a prominent inventor based in Handa, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of 12 patents to his name, he has made remarkable advancements in the field of drug development.

Latest Patents

One of his latest inventions includes the development of benzimidazole cyclooxygenase-2 inhibitors. This invention provides a compound of a specific formula that has potential therapeutic applications in treating various inflammatory conditions.

Career Highlights

Takashi Mano is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on innovative solutions that address critical health challenges.

Collaborations

Throughout his career, Takashi has collaborated with notable colleagues, including Rodney W. Stevens and Yoshiyuki Okumura. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

In summary, Takashi Mano is a distinguished inventor whose work in pharmaceutical chemistry continues to impact the industry positively. His innovative contributions and collaborations highlight his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…